HER2-positive Breast Cancer Registry

HER2-positive Breast Cancer Registry

Recruiting Observational Study
HER2 + Breast Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Priyanka Sharma · Other
Who this trial is looking for

This trial is looking for people with HER2-positive breast cancer. Participants will help researchers understand how certain patient or tumor characteristics affect outcomes in this type of cancer.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with stage I-IV HER2-positive breast cancer

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Stage I-IV HER2-positive breast cancer Exclusion Criteria: * None
Contacts

Study Coordinator

913-588-6079

PRO-HER2@kumc.edu

CONTACT